Estelle Vester Blokland
About Estelle Vester Blokland
Estelle Vester Blokland is the SVP, Global Head Medical Affairs at Bristol Myers Squibb, with 25 years of international experience in medical affairs and product strategy, specializing in Neuroscience and Oncology.
Current Role at Bristol Myers Squibb
Estelle Vester Blokland serves as the Senior Vice President and Global Head of Medical Affairs at Bristol Myers Squibb. She operates from the company’s office in Boudry, Neuchâtel, Switzerland. Her role involves overseeing global medical affairs strategies and initiatives, ensuring alignment with the company’s overall goals in drug development and patient care.
Previous Positions at Novartis
Estelle Vester Blokland worked at Novartis as the Worldwide Head of Medical Affairs Neuroscience from 2019 to 2021. In this capacity, she was responsible for the company's medical affairs strategies in the neuroscience domain across various markets. This role was based in the Basel Area, Switzerland.
Leadership Roles at F. Hoffmann-La Roche
Between 2017 and 2018, Estelle held several leadership roles at F. Hoffmann-La Roche. She served as the Head of Personalized Health Care and Medical Access, and briefly as the Disease Area Head for Pan-Oncology Strategy. Prior to these roles, from 2013 to 2017, she was the Life Cycle Leader for Alzheimer’s Disease, managing the product life cycle strategies for the disease area.
Career at Bristol-Myers Squibb
Estelle Vester Blokland has had an extensive tenure at Bristol-Myers Squibb spanning several roles. From 2005 to 2013, she worked in various capacities including Director of Abilify US Medical Affairs, Executive Director of Medical Affairs Neuroscience US, Executive Medical Director for European Markets, and European Disease Strategy Lead in Oncology. These roles were spread across locations in Plainsboro, NJ, USA and Paris, France.
Educational Background and Medical Expertise
Estelle earned her MD from Utrecht University, where she studied Medicine. With a professional background in both Neuroscience and Oncology, she is passionate about individualized patient care. Her expertise extends into rheumatology, particularly in diseases such as rheumatoid arthritis, psoriatic arthritis, lupus, and ankylosing spondylitis. Additionally, she has contributed to research in gastrointestinal immune-mediated diseases like inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE). She has been featured in a video discussing research on EoE.